Related Experiment Video

Updated: Aug 15, 2026

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
05:23

Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance

Published on: March 7, 2025

Helicobacter pylori: a review

D W Wood1, K P Block

  • 1Department of Medicine, Gastroenterology Division, University of Wisconsin, Madison 53792, USA.

American Journal of Therapeutics
|March 31, 1999
PubMed

Insights

Helicobacter pylori (H. pylori) infection is linked to stomach issues like gastritis and ulcers. This review examines current and future pharmacological treatments for H. pylori, focusing on efficacy and cost.

Area of Science:

  • Microbiology and Infectious Diseases
  • Gastroenterology
  • Pharmacology

Background:

  • Helicobacter pylori, a gram-negative bacterium discovered in 1982, is associated with significant gastrointestinal and non-gastrointestinal disorders.
  • H. pylori infection is a primary cause of gastritis, peptic ulcer disease, and gastric carcinoma.
  • Understanding the epidemiology, transmission, and virulence factors of H. pylori is crucial for effective management.

Purpose of the Study:

  • To review the pharmacological basis of current and emerging treatment options for H. pylori infections.
  • To evaluate the efficacy and economic considerations of various antimicrobial therapies.
  • To provide an overview of diagnostic tools and potential future interventions like vaccination.

Main Methods:

  • Literature review of pharmacological treatments for H. pylori.
  • Analysis of clinical efficacy data for antimicrobial regimens.
  • Examination of economic factors influencing treatment choices.
  • Discussion of diagnostic modalities and future therapeutic strategies.

Main Results:

  • Established antimicrobial treatments significantly improve cure rates for H. pylori-associated gastritis and ulcers.
  • Treatment reduces the recurrence rates of peptic ulcer disease.
  • Various diagnostic tools are available for H. pylori detection.
  • Vaccination strategies are under development for high-endemic regions.

Conclusions:

  • Effective pharmacological treatments are available for H. pylori infections, improving patient outcomes.
  • Economic considerations play a role in selecting appropriate treatment regimens.
  • Ongoing research into diagnostics and vaccines promises enhanced future management of H. pylori.

More Related Videos

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis04:56

Detection of Helicobacter pylori Infection and Antibiotic Resistance via Stool Quantitative Polymerase Chain Reaction Analysis

Published on: May 16, 2025

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology03:33

Rapid Detection of Fecal Antigen of Helicobacter pylori Infection Based on Double Antibody Sandwich Detection Technology

Published on: May 23, 2025

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds to M3...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the mucus...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
Peptic Ulcer Disease II: Pathophysiology01:24

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...